Cost of Revenue: Key Insights for Carlisle Companies Incorporated and Rentokil Initial plc

Cost of Revenue Trends: Carlisle vs. Rentokil

__timestampCarlisle Companies IncorporatedRentokil Initial plc
Wednesday, January 1, 20142384500000297500000
Thursday, January 1, 20152536500000310200000
Friday, January 1, 20162518100000376100000
Sunday, January 1, 20172941900000474900000
Monday, January 1, 20183304800000514200000
Tuesday, January 1, 201934399000002099000000
Wednesday, January 1, 202028325000002136400000
Friday, January 1, 202134956000002239100000
Saturday, January 1, 202244345000002737000000
Sunday, January 1, 20233042900000927000000
Monday, January 1, 20243115900000
Loading chart...

Unleashing the power of data

Analyzing Cost of Revenue Trends: Carlisle vs. Rentokil

A Decade of Financial Insights

Over the past decade, Carlisle Companies Incorporated and Rentokil Initial plc have showcased intriguing trends in their cost of revenue. From 2014 to 2023, Carlisle's cost of revenue surged by approximately 28%, peaking in 2022. This growth reflects Carlisle's strategic investments and operational expansions. In contrast, Rentokil's cost of revenue exhibited a more volatile pattern, with a significant spike in 2019 and 2020, followed by a notable decline in 2023, dropping by nearly 66% from its 2022 peak.

Key Insights

Carlisle's consistent upward trend suggests robust financial health and effective cost management strategies. Meanwhile, Rentokil's fluctuations highlight potential challenges in maintaining steady growth. These insights provide valuable perspectives for investors and stakeholders looking to understand the financial dynamics of these industry leaders.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
28 Jan 2025